Welcome to LookChem.com Sign In|Join Free
  • or
Hexanoic acid, 6-amino-, 2-[(2R)-2-[[[[4-[[(2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-methyl-1 -oxopentyl]amino]phenyl]methoxy]carbonyl]amino]-4-methyl-1-oxopentyl] hydrazide, 2,2,2-trifluoroacetate (1:1) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

919524-89-3

Post Buying Request

919524-89-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

919524-89-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 919524-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,9,5,2 and 4 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 919524-89:
(8*9)+(7*1)+(6*9)+(5*5)+(4*2)+(3*4)+(2*8)+(1*9)=203
203 % 10 = 3
So 919524-89-3 is a valid CAS Registry Number.

919524-89-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name N-((2R)-2-{[(4-{(2S)-2-[(tert-butoxy)carbonylamino]-4-methylpentanoylamino}phenyl)methoxy]carbonylamino}-4-methylpentanoylamino)-6-aminohexanamide trifluoroacetic acid salt

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:919524-89-3 SDS

919524-89-3Downstream Products

919524-89-3Relevant academic research and scientific papers

HYDRAZIDE CONJUGATES AS IMAGING AGENTS

-

Page/Page column 61, (2010/11/25)

The present disclosure is directed to diagnostic agents. More specifically, the disclosure is directed to compounds, diagnostic agents, compositions, and kits for detecting and/or imaging and/or monitoring a pathological disorder associated with coronary plaque, carotid plaque, aortic plaque, plaque of the arterial vessel, aneurism, vasculitis, and other diseases of the arterial wall. In addition, the disclosure is directed to methods of detecting and/or imaging and/or monitoring changes in the arterial wall, including expansive and constrictive remodeling, total vessel wall area, internal lumen size, and exterior artery perimeter.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 919524-89-3